IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,032,850 | -90.4% | 227,000 | -85.2% | 0.00% | -88.9% |
Q2 2023 | $10,778,613 | -31.0% | 1,531,053 | -40.1% | 0.03% | -40.0% |
Q1 2023 | $15,624,413 | +173.5% | 2,557,187 | +186.1% | 0.04% | +150.0% |
Q4 2022 | $5,712,232 | -57.7% | 893,933 | -36.7% | 0.02% | -60.9% |
Q3 2022 | $13,519,000 | +129.5% | 1,411,158 | +164.5% | 0.05% | +142.1% |
Q2 2022 | $5,891,000 | +183.2% | 533,600 | +327.2% | 0.02% | +216.7% |
Q1 2022 | $2,080,000 | -71.5% | 124,900 | -67.3% | 0.01% | -62.5% |
Q4 2021 | $7,290,000 | +14.2% | 381,881 | +47.5% | 0.02% | +14.3% |
Q3 2021 | $6,385,000 | +18.4% | 258,930 | +52.0% | 0.01% | 0.0% |
Q1 2021 | $5,392,000 | -62.2% | 170,300 | -44.6% | 0.01% | -65.9% |
Q4 2020 | $14,252,000 | +3937.4% | 307,162 | +2761.0% | 0.04% | +4000.0% |
Q3 2020 | $353,000 | -85.5% | 10,736 | -87.9% | 0.00% | -91.7% |
Q2 2020 | $2,432,000 | -53.6% | 88,609 | -53.2% | 0.01% | -25.0% |
Q4 2019 | $5,241,000 | -42.6% | 189,327 | -62.3% | 0.02% | -48.4% |
Q3 2019 | $9,132,000 | +540.8% | 501,770 | +234.9% | 0.03% | +520.0% |
Q1 2019 | $1,425,000 | -54.2% | 149,841 | -57.4% | 0.01% | -58.3% |
Q4 2018 | $3,111,000 | -7.7% | 351,532 | +33.4% | 0.01% | +20.0% |
Q2 2018 | $3,372,000 | +1287.7% | 263,475 | +1729.7% | 0.01% | +900.0% |
Q1 2018 | $243,000 | +7.5% | 14,400 | -49.1% | 0.00% | 0.0% |
Q4 2017 | $226,000 | – | 28,294 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |